Nectar Lifesciences Q2 Results
- BSE: 532649
- NSE: NECLIFE
- ISIN: INE023H01027
- Sector: Biotechnology & Drugs
BSE
12.12
-0.17 (-1.38%)
-0.17 (-1.38%)Volume22.59 K
Updated: Wed 9 Sep, 2026 | 15:28:31
NSE
12.00-0.15 (-1.23%)
-0.15 (-1.23%)Volume1.22 L
Updated: Wed 9 Sep, 2026 | 15:29:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Nectar Lifesciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 6.24 | 27.82 | 3490.28% | 6.77 | -7.80% |
| Depreciation/ Amortization | 0.20 | 0.11 | 135.68% | 0.45 | -54.64% |
| Operating Income | -0.53 | -27.38 | 217.66% | -1.04 | -48.77% |
| Net Income | -,176.01 | -15.40 | 178.35% | 5.60 | 0.00% |
| Other Operating Expenses Total | 1.93 | 26.64 | 2789.69% | 1.72 | 12.53% |
| Net Income Before Taxes | -0.51 | -24.62 | 0.00% | -0.35 | 44.46% |
| Total Revenue | 5.71 | 0.44 | 90552.38% | 5.73 | -0.38% |
| Selling/ General/ Admin Expenses Total | 0.75 | 1.06 | 3584.80% | 0.68 | 10.06% |
| Diluted Normalized EPS | -0.01 | -0.81 | 0.00% | -0.01 | 44.30% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.